These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23328606)

  • 1. Comparative evaluation of three commercial ELISA kits for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.
    Fukai K; Morioka K; Onozato H; Yoshida K; Sakamoto K
    J Vet Med Sci; 2013; 75(6):693-9. PubMed ID: 23328606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of an ELISA kit for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.
    Fukai K; Nishi T; Morioka K; Yamada M; Yoshida K; Kitano R; Yamazoe R; Kanno T
    J Vet Med Sci; 2016 Mar; 78(3):365-73. PubMed ID: 26498533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of two ELISA kits for detecting antibodies to a nonstructural protein of foot-and-mouth disease virus using serum samples collected from naturally and experimentally infected cows.
    Fukai K; Nishi T; Shimada N; Morioka K; Yamada M; Yoshida K; Yamakawa M
    J Vet Med Sci; 2018 Nov; 80(10):1624-1630. PubMed ID: 30135332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longevity of anti NSP antibodies and the sensitivity of a 3ABC ELISA - A 3 years follow up of repeatedly vaccinated dairy cattle infected by foot and mouth disease virus.
    Elnekave E; Shilo H; Gelman B; Klement E
    Vet Microbiol; 2015 Jul; 178(1-2):14-8. PubMed ID: 25937314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
    Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
    Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of an indirect enzyme-linked immunosorbent assay for detection of foot-and-mouth disease virus nonstructural protein antibody using a chemically synthesized 2B peptide as antigen.
    Inoue T; Parida S; Paton DJ; Linchongsubongkoch W; Mackay D; Oh Y; Aunpomma D; Gubbins S; Saeki T
    J Vet Diagn Invest; 2006 Nov; 18(6):545-52. PubMed ID: 17121081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multiplex Luminex assay for detecting swine antibodies to structural and nonstructural proteins of foot-and-mouth disease virus in Taiwan.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Tseng CH; Tsai HJ
    J Microbiol Immunol Infect; 2016 Apr; 49(2):196-207. PubMed ID: 25074628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ELISA based on the repeated foot-and-mouth disease virus 3B epitope peptide can distinguish infected and vaccinated cattle.
    Gao M; Zhang R; Li M; Li S; Cao Y; Ma B; Wang J
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1271-9. PubMed ID: 22207215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Confirmatory Foot-and-Mouth Disease Virus Antibody ELISAs to Identify Infected Animals in Vaccinated Populations.
    Tewari A; Ambrose H; Parekh K; Inoue T; Guitian J; Nardo AD; Paton DJ; Parida S
    Viruses; 2021 May; 13(5):. PubMed ID: 34063385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant non-structural polyprotein 3AB-based serodiagnostic strategy for FMD surveillance in bovines irrespective of vaccination.
    Mohapatra JK; Pandey LK; Sanyal A; Pattnaik B
    J Virol Methods; 2011 Nov; 177(2):184-92. PubMed ID: 21864578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies specific for foot-and-mouth disease virus infection using indirect ELISA based on recombinant nonstructural protein 2B.
    Biswal JK; Jena S; Mohapatra JK; Bisht P; Pattnaik B
    Arch Virol; 2014 Jul; 159(7):1641-50. PubMed ID: 24420160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a peptide-based immunochromatographic strip for differentiation of serotype O Foot-and-mouth disease virus-infected pigs from vaccinated pigs.
    Yang S; Yang J; Zhang G; Qiao S; Wang X; Zhao D; Li X; Deng R; Zhi A; You L; Chai S; Teng M
    J Vet Diagn Invest; 2010 May; 22(3):412-5. PubMed ID: 20453216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus.
    Jaworski JP; Compaired D; Trotta M; Perez M; Trono K; Fondevila N
    J Virol Methods; 2011 Dec; 178(1-2):191-200. PubMed ID: 21946290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of non-structural protein enzyme-linked immunosorbent assays for the detection of serum antibodies against foot-and-mouth disease virus in a target population in New Zealand.
    Kittelberger R; Mackereth GF; Sewell M; Keall J; Clough R; Pigott C; O'Keefe JS
    N Z Vet J; 2008 Oct; 56(5):227-32. PubMed ID: 18836503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth disease.
    Colling A; Morrissy C; Barr J; Meehan G; Wright L; Goff W; Gleeson LJ; van der Heide B; Riddell S; Yu M; Eagles D; Lunt R; Khounsy S; Than Long NG; Phong Vu P; Than Phuong N; Tung N; Linchongsubongkoch W; Hammond J; Johnson M; Johnson WO; Unger H; Daniels P; Crowther JR
    Aust Vet J; 2014 Jun; 92(6):192-9. PubMed ID: 24862997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a competitive enzyme-linked immunosorbent assay for detection of antibodies against the 3B protein of foot-and-mouth disease virus.
    Yang M; Parida S; Salo T; Hole K; Velazquez-Salinas L; Clavijo A
    Clin Vaccine Immunol; 2015 Apr; 22(4):389-97. PubMed ID: 25651918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.